Sort By

The U.S. Food and Drug Administration (FDA) has approved ExAblate Neuro, the first MRI-guided focused ultrasound device for the treatment of essential tremor in patients who have not responded well to conventional treatment.  Link to Article.

MR-guided focused ultrasound (MRgFUS) developer INSIGHTEC has received U.S. Food and Drug Administration (FDA) clearance for a new version of its Exablate device and a change in labeling.

The new version of system is cleared for the treatment of symptomatic uterine fibroids, and with the updated labeling, fibroid tissue ablation can now be considered for patients who wish to retain fertility, the company said.

Font Resize